Bacterial Resistance
in the News

CDC: Deadly, drug-defying CRE bacteria on rise in U.S. hospitals

‘We Have a Limited Window of Opportunity’: CDC Warns of Resistance ‘Nightmare’

Recent Achaogen News

Achaogen Awarded $60M Contract Option by BARDA for the Clinical Development of Plazomicin

Achaogen Announces All Objectives Met in Phase 2 Plazomicin Complicated Urinary Tract Infections Study and Start of First-in-Human Study with ACHN-975

PUBLICATIONS/POSTERS

A double-blind, randomized, placebo-controlled study to assess the safety, tolerability, plasma pharmacokinetics and lung penetration of intravenous plazomicin in healthy subjects

The pharmacokinetics (PK) and safety of plazomicin in subjects with renal impairment

Pharmacokinetics and Safety of Single and Multiple Doses of ACHN-490 Injection Administered Intravenously in Healthy Subjects

---